glucosamine has been researched along with Blood Clot in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavalheiro, RP; de Farias, EH; Fareed, J; Gray, AL; Herman, F; Hoppensteadt, D; Lima, MA; Nader, HB; Sassaki, GL; Viskov, C | 1 |
| Ayoub, N; Barete, S; Francès, C; Piette, JC | 1 |
2 other study(ies) available for glucosamine and Blood Clot
| Article | Year |
|---|---|
Ultra-low-molecular-weight heparins: precise structural features impacting specific anticoagulant activities.
Topics: Anticoagulants; Carbohydrate Sequence; Circular Dichroism; Enoxaparin; Glucosamine; Heparin; Heparin, Low-Molecular-Weight; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Weight; Oligosaccharides; Polymers; Spectrophotometry, Ultraviolet; Thrombosis; Uronic Acids | 2013 |
[Classification of dermatologic manifestations in lupus erythematosus].
Topics: Acitretin; Adrenal Cortex Hormones; Adult; Antimalarials; Clinical Trials as Topic; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Combinations; Female; Glucosamine; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infant, Newborn; Isotretinoin; Keratolytic Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Male; Middle Aged; Skin; Sulfasalazine; Thalidomide; Thrombosis; Ultraviolet Therapy; Vasculitis | 2003 |